NOLAN SEAN P. received a stock award from TAYSHA GENE THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/4/2024ACC: 0001209191-24-000807
+2.37M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.37M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.18M
Price / share
—
Trade value
—
% of position
101255.4%
1/2/2024
1.17K→1.19M
Total
Net shares
+1.18M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2024 | A · Award | +1.18M | — | — | 101255.4% | 1.17K | 1.19M |
| Total | +1.18M | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
1.18M shares
Shares
+1.18M
Strike price
1.71
Held after
1.18M
Exercisable
—
1/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock1.18M shares | 1/2/2024 | A · Award | +1.18M | 1.71 | — | 1.18M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.54M
Total
1.54M indirect1.54M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.54M | Indirect |
| Total | 1.54M | 1.54M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported